Home/Filings/4/0001437749-25-037171
4//SEC Filing

Cittadine Andrew 4

Accession 0001437749-25-037171

CIK 0001645469other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 4:50 PM ET

Size

7.0 KB

Accession

0001437749-25-037171

Insider Transaction Report

Form 4
Period: 2025-12-02
Cittadine Andrew
Chief Operating Officer
Transactions
  • Award

    Stock Options

    2025-12-02+8,9698,969 total
    Exercise: $75.94Exp: 2035-12-02Common Stock (8,969 underlying)
  • Award

    Restricted Stock Units

    2025-12-02+13,91952,593 total
    Exercise: $0.00Common Stock (13,919 underlying)
Footnotes (2)
  • [F1]Options vest 6/48ths on June 30, 2026, and 1/48th per month thereafter.
  • [F2]RSUs vest 6/48ths on June 30, 2026, and 3/48ths per quarter thereafter.

Issuer

Monopar Therapeutics

CIK 0001645469

Entity typeother

Related Parties

1
  • filerCIK 0001863624

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:50 PM ET
Size
7.0 KB